Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug-eluting stents do they make the difference? ].

P Presbitero1, M Asioli

  • 1Laboratorio di Emodinamica e Cardiologia Interventistica, Istituto di Clinica Humanitas, Rozzano, Milan, Italy.

Minerva Cardioangiologica
|October 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurological recovery after out-of-hospital cardiac arrest: hospital admission predictors and one-year survival in an urban cardiac network experience.

Minerva cardioangiologica·2013
Same author

Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: a meta-analysis of adjusted observational results.

International journal of cardiology·2013
Same author

Predictors of mortality in patients undergoing percutaneous aortic valve implantation.

Minerva cardioangiologica·2012
Same author

Multivessel disease in primary percutaneous coronary intervention.

Minerva cardioangiologica·2012
Same author

Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood.

Journal of thrombosis and haemostasis : JTH·2010
Same author

Percutaneous aortic valve in severe valvular regurgitation caused by infective endocarditis.

International journal of cardiology·2010

Drug-eluting stents show promise in reducing restenosis after percutaneous transluminal coronary intervention (PTCI). Sirolimus-eluting stents significantly suppress neointimal formation, while paclitaxel also demonstrates a low restenosis rate, offering new therapeutic avenues.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Restenosis, occurring in 30% of patients within 6 months post-PTCI, limits intervention success.
  • While coronary stenting reduces restenosis, smooth muscle cell proliferation remains a challenge.
  • Previous mechanical treatments and early drug therapies (cortisone, heparin) showed limited efficacy.

Purpose of the Study:

  • To evaluate the efficacy of novel antiproliferative and anti-inflammatory drugs delivered via stents to reduce restenosis.
  • To assess the impact of sirolimus-eluting stents and paclitaxel on neointimal hyperplasia and restenosis rates.

Main Methods:

  • Pilot studies and randomized controlled trials (Ravel, Sirius, Taxus I & II) evaluated drug-eluting stents (sirolimus, paclitaxel).

Related Experiment Videos

  • These trials assessed neointimal formation, hyperproliferation, and restenosis rates at various follow-up periods (6-12 months).
  • Drug-eluting stents were compared against control groups or standard stenting procedures.

    • Main Results:

    • Sirolimus-eluting stents demonstrated sustained suppression of neointimal formation and absence of restenosis in initial studies (Ravel trial).
    • The Sirius trial showed a lower, though not complete, inhibition of restenosis (9.2%) in more complex lesions.
    • Paclitaxel (Taxus trials) also indicated extremely low restenosis rates, with other drugs under investigation.

    Conclusions:

    • Drug-eluting stents, particularly those with sirolimus and paclitaxel, represent a significant advancement in reducing restenosis post-PTCI.
    • The combination of stent design, drug elution, and lesion coverage is crucial for optimal outcomes.
    • Further research is ongoing for other drug candidates to further improve restenosis prevention.